| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8804866 | Trauma Case Reports | 2018 | 4 Pages |
Abstract
Idarucizumab was clinically effective for reversing dabigatran, resulting in undetectable serum levels, and should be considered in patients presenting to hospital with clinically significant bleeding associated with dabigatran therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Gail Edwards, Cristina Roman, Rondhir Jithoo, Biswadev Mitra,